Decrease in serum levels of autotaxin in COVID-19 patients-Reference-Cited by-同舟云学术

Decrease in serum levels of autotaxin in COVID-19 patients

Published:2022-11-11 Issue:1 Volume:54 Page:3188-3199
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Shimura Takuya¹,Kurano Makoto¹²,Okamoto Koh³,Jubishi Daisuke³,Hashimoto Hideki³,Kano Kuniyuki⁴,Igarashi Koji⁵,Shimamoto Satoshi⁵,Aoki Junken⁴,Moriya Kyoji³,Yatomi Yutaka¹²

Affiliation:

1. Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan

2. Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

3. Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan

4. Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

5. Bioscience Division, TOSOH Corporation, Kanagawa, Japan

Funder

Mitsubishi Foundation

Leading Advanced Projects for medical innovation

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2143554

Reference58 articles.

1. Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review

2. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology

3. Neutralizing monoclonal antibodies for treatment of COVID-19

4. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

5. Dexamethasone in Hospitalized Patients with Covid-19

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis;Journal of Pharmacy and Pharmacology;2024-07-18

2. Lysophospholipids and their producing enzymes: Their pathological roles and potential as pathological biomarkers;Pharmacology & Therapeutics;2023-06